VIM and cystic fibrosis: Pharmacological inhibition of FAK significantly reversed the phenotypic transformation in hypoxia-induced CF, as demonstrated by decreased α-SMA and vimentin expression as well as decreased basal and hypoxia-stimulated phosphorylation of FAK tyrosine 397 (pY397 of FAK) in vitro.